CYTOTOXIC T-LYMPHOCYTE RESPONSES TO RECOMBINANT CANARYPOX-GP160 MN (ALVAC VCP125, HIV-1 GP160 MN) IN HIV-1 UNINFECTED ADULT VOLUNTEERS

被引：0
|
作者：
EGAN, MA [1 ]
WEINHOLD, K [1 ]
PAOLETTI, E [1 ]
TARTAGLIA, J [1 ]
CLEMENTS, ML [1 ]
PAVLAT, W [1 ]
SILICIANO, RF [1 ]
机构：
[1] JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD 21205
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 1994年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S89 / S89
页数：1
相关论文
共 50 条
  • [1] Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type I (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp160 of HIV-1 and boosted with a recombinant gp160
    Fleury, B
    Janvier, G
    Pialoux, G
    Buseyne, F
    Robertson, MN
    Tartaglia, J
    Paoletti, E
    Kieny, MP
    Excler, JL
    Riviere, Y
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (04): : 734 - 738
  • [2] ANALYSIS OF CYTOTOXIC T-LYMPHOCYTE RESPONSES ELICITED BY A RECOMBINANT VACCINIA VECTOR ENCODING HIV-1 GP160 AND ENVELOPE SUBUNIT PROTEIN VACCINES IN HIV-1 UNINFECTED RECIPIENTS
    MCELRATH, J
    COREY, L
    HOFFMAN, M
    KLUCKING, S
    RABIN, M
    GREENBERG, P
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S48 - S48
  • [3] Immunisation with gp160 in HIV-1 infection
    Flala, C
    Stewart, GT
    [J]. LANCET, 1999, 354 (9182): : 948 - 948
  • [4] Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers
    Belshe, RB
    Gorse, GJ
    Mulligan, MJ
    Evans, TG
    Keefer, MC
    Excler, JL
    Duliege, AM
    Tartaglia, J
    Cox, WI
    McNamara, J
    Hwang, KL
    Bradney, A
    Montefiori, D
    Weinhold, KJ
    [J]. AIDS, 1998, 12 (18) : 2407 - 2415
  • [5] HUMAN-IMMUNODEFICIENCY-VIRUS (HIV-1) GP160-SPECIFIC LYMPHOCYTE PROLIFERATIVE RESPONSES OF MONONUCLEAR LEUKOCYTES FROM HIV-1 RECOMBINANT GP160 VACCINE RECIPIENTS
    KEEFER, MC
    BONNEZ, W
    ROBERTS, NJ
    DOLIN, R
    REICHMAN, RC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (03): : 448 - 453
  • [6] Immunisation with gp160 in HIV-1 infection -: Reply
    Sandstöm, EG
    Wahren, B
    [J]. LANCET, 1999, 354 (9182): : 949 - 949
  • [7] COMPLEMENT ACTIVATION BY GP160 GLYCOPROTEIN OF HIV-1
    THIEBLEMONT, N
    HAEFFNERCAVAILLON, N
    WEISS, L
    MAILLET, F
    KAZATCHKINE, MD
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (03) : 229 - 233
  • [8] Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine
    Lambert, JS
    Viscidi, R
    Walker, MC
    Clayman, B
    Winget, M
    Wolff, M
    Schwartz, DH
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (03) : 302 - 308
  • [9] SYNTHESIS AND PROCESSING OF HIV-1 GP160 IN CELLS WITH DEFECTIVE HIV-1 GENOMES
    KALYANARAMAN, VS
    RODRIGUEZ, V
    GALLO, RC
    SARNGADHARAN, MG
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (02) : 197 - 197
  • [10] HIV-1 RECOMBINANT GP160 VACCINE GIVEN IN ACCELERATED DOSE SCHEDULES
    GORSE, GJ
    SCHWARTZ, DH
    GRAHAM, BS
    MATTHEWS, TJ
    STABLEIN, DM
    FREY, SE
    BELSHE, RB
    CLEMENTS, ML
    WRIGHT, PF
    EIBL, M
    FAST, PE
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1994, 98 (02): : 178 - 184
12345